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Pre-pregnancy obesity and risk of congenital abnormalities of the kidney and urinary tract 
(CAKUT) – systematic review, meta-analysis and ecological study  
 
ABSTRACT: 
INTRODUCTION: There is increasing evidence that maternal obesity is associated with 
several structural birth defects. Congenital abnormalities of the kidney and urinary tract 
(CAKUT) account for 30 to 50% of children starting kidney replacement therapy (KRT). We 
conducted a systematic review, meta-analysis and ecological study to explore the 
relationship between maternal obesity and CAKUT. 
 
METHODS: A systematic literature search was conducted in EMBASE, MEDLINE, Global 
Health, The Cochrane Library, Scopus and Web of Science. Study quality was assessed for 
bias and confounding. A meta-analysis using a random effect model was carried out to 
obtain a summary odds ratio (OR) and 95% confidence interval (CI). In the ecological study, 
country level data were used to examine the correlation of secular trends in female obesity, 
CAKUT incidence and incidence of KRT. 
 
RESULTS: Eight epidemiological studies were included in the review, 4 cohort studies and 4 
case-control studies, 7 of which were included in the meta-analysis. There was evidence of a 
positive association between obesity during pregnancy and the risk of CAKUT, with a 
summary OR = 1.14 (1.02 – 1.27). No association was seen with overweight, nor a dose 
response with increasing obesity. There was an increasing trend in countries’ proportion of 
female obesity and an increasing trend in reported CAKUT incidence with specific rises seen 
in congenital hydronephrosis (CH) and multi-cystic kidney dysplasia (MCKD). 
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CONCLUSION: Our findings suggest that pre-pregnancy obesity may be associated with 
increased risk of CAKUT at population level. 
 
Key words: pre-pregnancy obesity; CAKUT (congenital anomalies of the kidney and urinary 





Obesity is a major public health issue and its prevalence continues to rise worldwide[1]. 
There is increasing evidence that maternal obesity is associated with several structural birth 
defects[2-4].   Congenital abnormalities of the kidney and urinary tract (CAKUT) account for 
30 to 50% of children starting KRT[5] and occur in around 0.4 to 4 per 1000 pregnancies 
[6,7].  Although milder forms of CAKUT can remain asymptomatic, others will give rise either 
in infancy or later in life to recurrent urinary tract infections, hypertension or kidney 
insufficiency[6,8]. CAKUT is often an isolated condition with gene abnormalities accounting 
for approximately 15% of cases[9], can occur in families and in hundreds of syndromes[10]. 
Variations of the CAKUT phenotype within families and the variable expressivity of CAKUT-
causing genes point to environmental factors, maternal obesity being one of them [9]. 
Animal studies have shown that maternal hyperglycaemia and maternal obesity can affect 
kidney development in the offspring[11,12]. Maternal type 1 diabetes mellitus (DM) and 
gestational DM (GDM) are known to increase the risk of congenital malformations[13,14] 
including CAKUT[15]. The effect of maternal obesity on CAKUT is less well known with 
studies showing different results[16,17].  
The aim of this study was to systematically review the evidence and pool data that examined 
the association of obesity during pregnancy and CAKUT. As a secondary aim we conducted 
an ecological study to examine population trends in maternal obesity and incidence of 
CAKUT.  
 
MATERIALS and METHODS 
Systematic Review and Meta-Analysis: 
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These were conducted following PRISMA guidelines[18]. The protocol is registered on 
PROSPERO (PROSPERO ID 121709). 
Criteria for inclusion were that studies were conducted in humans, had obesity as the 
defined exposure, indicated congenital abnormalities as an outcome, had a direct control 
group, were published in English and were peer-reviewed. 
The literature search was conducted up to November 2018 using EMBASE (from 1947), 
MEDLINE (from 1879), Global Health (from 1973), The Cochrane Library (from 1996), Scopus 
(from 2004) and Web of Science (from 1900). 
Searches using free-text and MeSH terms were done and the domains were obesity, 
pregnancy, congenital anomalies/abnormalities and birth registry or medical records, in 
order to identify studies on large populations with sufficient number of CAKUT outcomes 
(Supplementary File (SF) A). Under the domain “congenital abnormalities, we included: 
CAKUT, Vesico-ureteric/vesico-ureteral reflux, Renal/kidney dysplasia, Renal/kidney 
dysgenesis, Renal/kidney agenesis, Renal/kidney hypoplasia, Multicystic kidney dysplasia 
(MCD), Obstructive urinary defect, Obstructive genito-urinary defect, Megaureter, Pelvic 
ureteric, Hydronephrosis, Posterior urethral valves, Renal abnormality/anomaly, Urinary 
abnormality/anomaly, Kidney abnormality/anomaly, Renal/kidney cysts/cystic. 
Study selection 
Duplicates were removed. All titles and abstracts were examined by one reviewer (HA). Full 
text searches were made looking for urinary/kidney abnormalities if these were not 
mentioned in the abstract. A sample of 100 references were selected randomly and 
evaluated by a second reviewer (DN). There was full agreement. 
Data collection process 
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A predesigned form was used to record extracted data that included study design, author 
name, year, setting, study population, CAKUT abnormality, definition of obesity and obesity 
subgroups, ascertainment, selection of control group, number of CAKUT cases in non-obese 
and in obese groups,  crude and adjusted odds ratio (OR) and 95% confidence intervals 
(95%CI) and confounders.  
Quality assessment 
Risk of bias was assessed by HA, DN and LJ, using the following criteria: selection bias, 
information bias in the measurement of pre-pregnancy BMI and in the diagnosis and 
ascertainment of CAKUT cases. Study quality was further assessed by looking at adjustment 
for key confounders: maternal age, race/ethnicity, smoking, maternal diabetes status, folic 
acid use and socioeconomic status: maternal education, maternal parity (SF B for other 
desirable confounders). Studies were assigned high risk, low risk or uncertain according to 
the above criteria and were colour coded.  
Meta-analysis  
The main exposure was maternal obesity at time of conception or during the first trimester 
of pregnancy (“pre-pregnancy obesity”). The outcome was any form of CAKUT as defined in 
individual studies. Meta-analysis was performed in studies containing the OR or risk ratio 
(RR), comparing the incidence of CAKUT in maternal obese group and in non-obese group. If 
a study only reported a risk ratio for CAKUT for different levels of obesity, each measure of 
effect was included in the meta-analysis, otherwise we used the overall measure. The 
standard error for each study was calculated from log OR and log 95% CI. A pooled adjusted 
OR and 95% CI across studies was computed using a random effects model using Stata 
version 13 (www.stata.com). A subgroup analysis was carried based on study design. The 
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data were displayed in forest plots. We also obtained a pooled estimate for the association 
between CAKUT and obesity subclasses and overweight.  
Heterogeneity was quantified by calculating I², classified as 0-40% = might not be important; 
30-60% = moderate; 50-90% =  may represent substantial heterogeneity; 75-100% = 
considerable heterogeneity [19]. To exclude the possibility that a study exerted excessive 
influence on the heterogeneity, we conducted a sensitivity analysis by omitting 1 study at a 
time. We assessed the presence of publication bias using funnel plots and the Egger test 
where a p value of less than 0.10 was interpreted as supporting publication bias. 
Ecological study 
The main exposure for the ecological study was the countries’ age standardised prevalence 
(ASP) of obesity per year in women aged 18 years or older. Obesity was defined as a BMI of 
30 or above. We used the data published by the WHO (SF C). Other country level exposures 
explored were the ASP of raised fasting blood glucose and smoking in females, countries’ 
gross domestic product (GDP), inequality using the GINI index. Outcome data consisted of a) 
the annual incidence per country of CAKUT (overall and specific diagnosis), data derived 
from EUROCAT[20], a European network of population-based registries for the surveillance 
of congenital abnormalities where cases are classified based on ICD10 with the British 
Paediatric Association extension and include livebirths, foetal deaths from 20 weeks 
gestational age and terminations of pregnancy for foetal anomaly at any gestation. The 
urinary abnormalities included in EUROCAT’s surveillance are: bilateral kidneyagenesis,  
MCKD, congenital hydronephrosis (kidney pelvis diameter ≥ 10mm after birth), bladder 
exstrophy, posterior urethral valves and/or prune belly) b) the annual proportion per 
country of CAKUT as the primary kidney pathology in children under 15 years entering RRT in 
European countries derived from ERA-EDTA data and c) the incidence per country of young 
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We initially identified 2107 articles. After removal of duplicates 1417 articles remained. 
Forty-five studies met our criteria and after assessment of their full text, 37 were excluded 
(Figure 1, SF D).  The number of studies retrieved from each database is given in SF E. Eight 
studies were left after exclusions: 4 cohort studies (Block[17], Blomberg[21], Garcia-
Patterson[22] and Persson[23]) and four case-control studies (Honein[24], Oddy[25], 
Slickers[16] and Tromp[26]), see Table 1.  
Exposure Definition:  
Obesity was defined using the WHO classification of BMI, as a BMI≥30 [27] in all studies 
except Garcia-Patterson which used BMI tertiles, upper tertile was a BMI of 24.78-47.07. 
This was similar to the “high BMI” group in the Honein study (BMI ≥ 25). Three cohort 
studies (Block, Blomberg and Persson) further subdivided obesity into 3 WHO subclasses 
(Class I: BMI ≥ 30 ≤ 35, Class II: BMI ≥ 35 ≤ 40 and Class III: BMI ≥ 40)[28] ; Block and Persson 
provided effect measures for obesity and for the specific subclasses of obesity, Persson 
provided these for each subclass only. Except for the Honein study, the rest of the studies 
provided a separate effect measure for overweight; this corresponded to the 2nd tertile in 
the Garcia-Patterson study. All but one study used the pre-pregnancy weight as recollected 
by the mother for the pre-pregnancy BMI calculation. The Persson study used early 





The diagnosis of CAKUT was based on the International Classification of Diseases, edition 9 
or 10 in all studies except for the Garcia-Patterson which used a non-standardised definition. 
The outcome was reported with all CAKUT diagnoses grouped together under “Urinary 
Abnormalities” using ICD-9 or 10 codes in Persson and Oddy, without further details, 
excluding known chromosomal, genetic or syndrome diagnoses.  Garcia-Patterson grouped 
them as Renal/Urinary without further details. The rest of the studies provided definition of 
outcomes giving details of the specific diagnoses included.  Persson had a separate Genital 
abnormalities outcome. Garcia-Patterson and Oddy didn’t and it is possible that minor 
anomalies, especially hypospadias, were included. Specific CAKUT diagnoses were used as 
outcome in Block (Obstructive Genito-Urinary Defect, Renal Agenesis (RA)/hypoplasia) and in 
Blomberg (Cystic kidney, RA/hypoplasia), in Honein (RA/Hypoplasia, Obstructive defects, 
Renal or Ureter duplication), in Slickers (RA/Hypoplasia), in Tromp (Bilateral RA, MCD, 
congenital hydronephrosis (kidney AP≥ 10 mm), bladder exstrophy or epispadias, posterior 
urethral valves or prune belly syndrome).  
The age at diagnosis of CAKUT was at birth or in the neonatal period in Blomberg, Persson 
and Garcia-Patterson, by 1 year of age in Block, Honein and Slickers, by 6 years of age in 
Oddy and by 10 years of age in Tromp. 
Quality Assessment: 
Cohort studies: There were four cohort studies, two from Sweden (Blomberg and Persson) 
which were nationally based, one from Spain, based at a hospital in Barcelona (Garcia-
Patterson) and a regional study in the USA (Block) based in Florida (Table 1). The total 
sample size consisted of 3419969 pregnancies and 9459 CAKUT cases. The populations in 
Block, Blomberg and Persson were over a million with hundreds of cases, in contrast to the 
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small cohort in Garcia-Patterson with just over two thousand participants. The study periods 
span the years from 1986 to 2014. Blomberg, Block and Persson excluded known 
chromosomal syndromes; in addition, Persson excluded infants with genetic or 
malformation syndromes as well as congenital viral infections linked to malformations. This 
is unknown for the Garcia-Patterson study.  
Only Block excluded mothers with pre-existing diabetes but included GDM. Blomberg and 
Persson included both types. GDM was included in all studies and was present in 7,5% of 
obese mothers in Block, not stated in the others. Only Persson carried out a sensitivity 
analysis excluding all diabetes which showed no difference in the estimate. Garcia-Paterson 
studied high BMI in mothers with GDM.  
Case-control studies: The four case-controlled studies originated from Australia (Oddy), the 
USA (Honein and Slickers) and from the Netherlands (Tromp) (Table 1). There was a total of 
765 cases and 5616 controls. The oldest study is Honein with data from 1968 to 1980. The 
three other studies have data from 1997 to 2010. Cases were identified from regional or 
state level registries and included CAKUT occurring in live births, stillbirths and foetal deaths. 
Cases with known chromosomal abnormalities were excluded. Controls were selected from 
healthy infants born in the same area and period of time as the cases except for Tromp 
where controls were live infants or foetuses with a known syndrome, chromosomal or 
monogenic anomaly. Slickers and Honein excluded mothers with pre-existing diabetes. Oddy 
performed a sensitivity analysis which showed no difference. GDM was excluded by Honein 
and adjusted for by Slickers but not by Oddy or Tromp and was present in 1.2% of obese 
women in the Tromp study, not stated in the others. 
See Table 2 for summary of quality criteria and assessment (details in SF F). Overall, the quality 
of cohort studies was higher showing low selection bias through the use of population-based 
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birth registries with the exception of Garcia-Patterson where the selection process was 
uncertain. There was a lack of detail on the conditions of the exposure measurement in Block 
and Garcia-Patterson.  Measurement of the outcome was mostly unbiased helped using birth 
registries which had defined diagnostic classification and the use of defined age of 
ascertainment of the diagnosis of CAKUT, except for the Blomberg study where this varied 
from birth to 13 years of age. In all but one study there was an acceptable level of adjustment 
for confounders.  
The case-control studies had a high risk of information bias arising from the use of self-
reported maternal pre-pregnant BMI obtained after the outcome and at various times after 
birth. Adjustment for key confounders was poor in two and adequate in two studies. The 
effect estimate was higher in case-control studies, which also had wider confidence limits. 
 
Meta-analysis 
García-Patterson study was excluded from the meta-analysis because it was conducted 
amongst women with GDM, which is on the causal pathway between BMI (the exposure of 
interest) and CAKUT. This left 4 case control studies and 3 cohorts.  
The individual study ORs were of similar order of magnitude with considerable overlap of 
95% CI (Figure 2). The results indicated a positive association between pre-pregnancy 
obesity and CAKUT with an overall pooled OR of 1.14 (1.02 – 1.27). There was a moderate 
degree of heterogeneity with an I2 of 51.5%, p=0.024, with the Persson study explaining 
most of the heterogeneity. When this study was omitted the OR was 1.23 (1.09-1.39) 
I2=26.7%, p=0.216. Omitting the Honein paper (which grouped together overweight and 
obese) from the obese group resulted in a very minimal increase in the summary estimate 
(see SF G).  The subgroup cohort summary estimate was smaller and had narrower 95% CI 
12 
 
than the that of case-control studies although there was low statistical evidence of a 
difference (p=0.06). There was no clear evidence of a “dose-response” effect with increasing 
Obesity (SF H). There was no association with overweight, pooled OR was 1.02 (0.97 – 1.07), 
I2 = 0.0%, p=0.958 (SF I). Neither the funnel plot nor the Egger test suggested publication 
bias (SF J). 
Ecological study:  
Data from 21 European countries from 1980 show an upward trend in female obesity (Figure 
3) which coincides with an increase in the yearly incidence of CAKUT (Figure 4). When the 
relationship with female obesity is examined in more detail for specific CAKUT diagnoses, 
only the incidence of Congenital Hydronephrosis and of MCKD seem to increase whilst the 
other two remain stable[20] (SF K). Individual country plots of proportion of female obesity 
against each specific CAKUT diagnosis seemed to confirm this pattern (SF L). There was no 
increase in the proportion of children with a CAKUT diagnosis entering KRT when looking at 
European data from 1980 onwards (SF M-a). We then explored whether secular trends in 
children starting KRT mirrored the increase in female obesity. We assumed that the 
proportion entering KRT with a CAKUT diagnosis would remain the same in each country 
over the period studied. Using data from a wide range of countries worldwide on the yearly 
incidence of all children starting KRT from the late 1990s we found that there was no overall 
proportional increase (SF M-b). The only country where the RRT incidence (in < 25-year olds) 
mirrored the increase in female obesity was Malaysia.  There were no associations between 




In this study, we have We found that maternal obesity may be a risk factor for CAKUT. The 
meta-analysis showed a small but positive association between pre-pregnancy obesity and 
CAKUT. This was not seen with overweight in pregnancy nor did we find a dose response 
with increasing obesity.  The size of the association is similar to the level of risk found in 
comparable meta-analysis of pre-pregnancy obesity and other congenital defects[4].  
The results of the ecological study suggested that as female obesity increased so had the 
overall number of CAKUT diagnoses. 
The mechanisms for this association are not clear. Maternal obesity is associated with a 
wide range of metabolic abnormalities, but little is known about their potential effect 
epigenetic effects.[29] 
Our results were mainly driven by papers based on large-population birth registries with 
most studies using external, well standardised definitions of the exposure and outcome. 
Cohorts and case-control studies were characterised by low selection bias since data were 
mainly obtained from birth registries and by low bias in assessing the outcome. Most studies 
had adjusted for key confounders, and therefore this small association seen may be 
potentially real.  
Our study suffers from some limitations. We conducted the meta-analysis on aggregated 
data rather than individual data. However, the absolute number of participants and events 
was very high and therefore the summary estimate is likely to be similar with either 
method[30,31]. In the studies included in the meta-analysis, there was clinical heterogeneity 
arising from differences in outcomes definitions, with CAKUT diagnoses either grouped 
together or analysed individually. Grouping may have increased the power of these studies 
but this may not be the right approach  as the risk may vary depending on the specific 
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CAKUT diagnosis. There was some suggestion from the ecological study that only congenital 
hydronephrosis and MCKD showed increases as female obesity increased.. Confounding by 
pre-existing diabetes was adequately addressed except for one study (Bloomberg). All 
studies in the meta-analysis except Honein’s included infants of mothers with GDM which 
may lie in the causal pathway between obesity and CAKUT. Only Persson performed a 
sensitivity analysis excluding GDM mothers.  Slickers adjusted for GDM; however, if GDM 
lies in the causal pathway, this adjustment would probably result in a lower estimate. 
However, where available, the proportion of obese women with GDM was very small. The 
association of gestational DM and CAKUT was independent of pre-pregnancy BMI[15]. 
Although our results would suggest that pre-pregnancy BMI may have a threshold effect on 
kidney development, the absence of a dose related effect might be due to small numbers of 
CAKUT outcomes in the obesity sub-categories. The ecological study may be showing  
secular increases in the ascertainment of CAKUT related to increased reporting, for example 
of mild congenital hydronephrosis, or to the greater availability of prenatal ultrasound, 
occurring in parallel to increases in female obesity. This explanation, however, is less likely 
to apply to conditions such as MCKD, which shows definitive and more obvious features on 
prenatal ultrasound. . The findings from the ecological study showing secular, parallel 
increases in female obesity and in the diagnoses of congenital hydronephrosis and MCKD 
should not be used to interpret individual risk and should instead be regarded as sources for 
hypotheses to be tested in further studies.  Diagnosis evident at birth rely on prenatal 
ultrasound findings, usually performed by 20 weeks gestation. CAKUT may become 
apparent later in gestation and ultrasonography is technically more difficult in obesity, 
conceivably missing a CAKUT diagnosis altogether. CAKUT may become apparent later in life 
and may be underdiagnosed in young adults presenting in CKD stage 5[32]. This differential 
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bias would underestimate the effect of maternal obesity.   Case-control studies had wider 
95% CI and their use of self-reported pre-pregnancy weight increased information bias. The 
cohort sub-estimate, although smaller, may be more accurate. There is a lack of studies 
from middle- and low-income countries.  
Implications: 
This  increase in risk, even though small, needs to be seen as potentially adding to the 
burden of disease linked to pre-pregnancy obesity such as increased risk of other congenital 
abnormalities as already mentioned and increased risk in long term obesity and increased 
cardiometabolic risk in the offspring[33,34]. There is a  public health dimension to the 
findings of our study because obesity continues to rise worldwide, especially in females[1]. 
Management of obesity at the start of antenatal care may be too late because the first 
glomeruli form between 9 to 10 weeks gestation and the kidney development will have 
completed its morphological changes by 20 weeks. Public health measures that address the 
obesogenic nature of living environments are going to be more effective.  
The association found is small and it is not possible at this stage to be certain about the 
clinical implications of our findings on an individual context beyond continuing being 
proactive on encouraging a healthy lifestyle in our paediatric patients.  
This association should be the subject of further studies in different populations, focussing 
on specific CAKUT diagnoses..  The importance of birth registries in this context is 
paramount. The impact of the associations seen may be greater in settings where there is 
poor or no access to paediatric urological care. Further research on potential mechanisms to 




Our analysis suggests that pre-pregnancy obesity may be a risk factor for CAKUT, but this 







1. WHO Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-
overweight. Accessed 26/02/2020 2020 
2. Stothard KJ, Tennant PW, Bell R, Rankin J (2009) Maternal overweight and obesity and the risk of 
congenital anomalies: a systematic review and meta-analysis. JAMA 301 (6):636-650. 
doi:10.1001/jama.2009.113 
3. Huang HY, Chen HL, Feng LP (2017) Maternal obesity and the risk of neural tube defects in 
offspring: A meta-analysis. Obes Res Clin Pract 11 (2):188-197. doi:10.1016/j.orcp.2016.04.005 
4. Zhu Y, Chen Y, Feng Y, Yu D, Mo X (2018) Association between maternal body mass index and 
congenital heart defects in infants: A meta-analysis. Congenit Heart Dis 13 (2):271-281. 
doi:10.1111/chd.12567 
5. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in 
children. Pediatr Nephrol 27 (3):363-373. doi:10.1007/s00467-011-1939-1 
6. Andres-Jensen L, Jorgensen FS, Thorup J, Flachs J, Madsen JL, Maroun LL et al. (2016) The outcome 
of antenatal ultrasound diagnosed anomalies of the kidney and urinary tract in a large Danish birth 
cohort. Arch Dis Child 101 (9):819-824. doi:10.1136/archdischild-2015-309784 
7. Tain Y-L, Luh H, Lin C-Y, Hsu C-N (2016) Incidence and Risks of Congenital Anomalies of Kidney and 
Urinary Tract in Newborns: A Population-Based Case-Control Study in Taiwan. Medicine 95 
(5):e2659-e2659. doi:10.1097/MD.0000000000002659 
8. Nef S, Neuhaus TJ, Sparta G, Weitz M, Buder K, Wisser J et al. (2016) Outcome after prenatal 
diagnosis of congenital anomalies of the kidney and urinary tract. Eur J Pediatr 175 (5):667-676. 
doi:10.1007/s00431-015-2687-1 
9. Nicolaou N, Renkema KY, Bongers EM, Giles RH, Knoers NV (2015) Genetic, environmental, and 
epigenetic factors involved in CAKUT. Nat Rev Nephrol 11 (12):720-731. 
doi:10.1038/nrneph.2015.140 
10. Limwongse C (2009) Syndromes and Malformations of the Urinary Tract. In: Editors: Avner EDHW 
HW, Niaudet P, Yoshikawa N (ed) Pediatric Nephrology, 6th Edition, vol 1. Springer, Berlin, pp 122-
138 
11. Kanwar YS, Nayak B, Lin S, Akagi S, Xie P, Wada J et al. (2005) Hyperglycemia: its imminent effects 
on mammalian nephrogenesis. Pediatr Nephrol 20 (7):858-866. doi:10.1007/s00467-005-1888-7 
12. Glastras SJ, Chen H, McGrath RT, Zaky AA, Gill AJ, Pollock CA et al. (2016) Effect of GLP-1 




13. Zhao E, Zhang Y, Zeng X, Liu B (2015) Association between maternal diabetes mellitus and the 
risk of congenital malformations: A meta-analysis of cohort studies. Drug Discov Ther 9 (4):274-281. 
doi:10.5582/ddt.2015.01044 
14. Balsells M, Garcia-Patterson A, Gich I, Corcoy R (2009) Maternal and fetal outcome in women 
with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol 
Metab 94 (11):4284-4291. doi:10.1210/jc.2009-1231 
15. Parimi M, Nitsch D (2020) A Systematic Review and Meta-Analysis of Diabetes During Pregnancy 
and Congenital Genitourinary Abnormalities. Kidney International Reports. 
doi:https://doi.org/10.1016/j.ekir.2020.02.1027 
16. Slickers JE, Olshan AF, Siega-Riz AM, Honein MA, Aylsworth AS (2008) Maternal body mass index 
and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth 
Defects Prevention Study. Am J Epidemiol 168 (11):1259-1267. doi:10.1093/aje/kwn248 
17. Block SR, Watkins SM, Salemi JL, Rutkowski R, Tanner JP, Correia JA et al. (2013) Maternal pre-
pregnancy body mass index and risk of selected birth defects: evidence of a dose-response 
relationship. Paediatr Perinat Epidemiol 27 (6):521-531. doi:10.1111/ppe.12084 
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. BMJ 339. doi:10.1136/bmj.b2535 
19. Higgins JPT G, S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, 
Chapter 10. The Cochrane Collaboration; 2011, . 
https://training.cochrane.org/handbook/current/chapter-10.  
20. EUROCAT European network of population-based registries for the epidemiological surveillance 
of congenital anomalies. European Commission. https://eu-rd-platform.jrc.ec.europa.eu/eurocat. 
2019 
21. Blomberg MI, Kallen B (2010) Maternal obesity and morbid obesity: the risk for birth defects in 
the offspring. Birth Defects Res A Clin Mol Teratol 88 (1):35-40. doi:10.1002/bdra.20620 
22. Garcia-Patterson A, Erdozain L, Ginovart G, Adelantado JM, Cubero JM, Gallo G et al. (2004) In 
human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body 
mass index and to severity of diabetes. Diabetologia 47 (3):509-514. doi:10.1007/s00125-004-1337-3 
23. Persson M, Cnattingius S, Villamor E, Soderling J, Pasternak B, Stephansson O et al. (2017) Risk of 
major congenital malformations in relation to maternal overweight and obesity severity: cohort 
study of 1.2 million singletons. BMJ 357:j2563. doi:10.1136/bmj.j2563 
24. Honein MA, Moore CA, Watkins ML (2003) Subfertility and prepregnancy overweight/obesity: 
possible interaction between these risk factors in the etiology of congenital renal anomalies. Birth 
Defects Res A Clin Mol Teratol 67 (8):572-577. doi:10.1002/bdra.10077 
25. Oddy WH, De Klerk NH, Miller M, Payne J, Bower C (2009) Association of maternal pre-pregnancy 
weight with birth defects: evidence from a case-control study in Western Australia. Aust N Z J Obstet 
Gynaecol 49 (1):11-15. doi:10.1111/j.1479-828X.2008.00934.x 
26. Tromp L, de Walle HEK (2012) Pre-pregnant maternal obesity increases risk of several congenital 
anomalies, in particular neural tune defects in the offspring. UMCG EUROCAT Northern Netherlands 
http://scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2012/TrompL/TrompL.pdf 
27. WHO: World health statistics 2009. Geneva: World Health Organization 2009.  
28. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO 
consultation. World Health Organ Tech Rep Ser 894:i-xii, 1-253 
29. Catalano PM, Shankar K (2017) Obesity and pregnancy: mechanisms of short term and long term 
adverse consequences for mother and child. BMJ 356:j1. doi:10.1136/bmj.j1 
30. Tudur Smith C, Marcucci M, Nolan SJ, Iorio A, Sudell M, Riley R et al. (2016) Individual participant 
data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database Syst 
Rev 9 (9):Mr000007. doi:10.1002/14651858.MR000007.pub3 
31. Tierney JF, Fisher DJ, Burdett S, Stewart LA, Parmar MKB (2020) Comparison of aggregate and 
individual participant data approaches to meta-analysis of randomised trials: An observational study. 
PLoS Med 17 (1):e1003019. doi:10.1371/journal.pmed.1003019 
18 
 
32. Neild GH (2009) What do we know about chronic renal failure in young adults? I. Primary renal 
disease. Pediatr Nephrol 24 (10):1913-1919. doi:10.1007/s00467-008-1108-3 
33. Gaillard R, Steegers EA, Duijts L, Felix JF, Hofman A, Franco OH et al. (2014) Childhood 
cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study. 
Hypertension 63 (4):683-691. doi:10.1161/hypertensionaha.113.02671 
34. Voerman E, Santos S, Patro Golab B, Amiano P, Ballester F, Barros H et al. (2019) Maternal body 
mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An 
individual participant data meta-analysis. PLoS Med 16 (2):e1002744. 
doi:10.1371/journal.pmed.1002744 
35. Organization WH Body Mass Index. http://www.euro.who.int/en/health-topics/disease-
prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.  
36. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in 






Table 1. Characteristics of eligible studies 
Cohort studies: 
 Obesity CAKUT Confounders 
adjusted 
Study Setting Population Definition Ascertained Definition Specification Ascertained  
Block  
2013 
Florida, USA Florida resident 
mothers without 
pre-gestational 
diabetes who gave 
birth to live 
singleton infants 
from March 2004 
through December 
2009 (1,124,370 
infants, 3987 cases 
of Obstructive 
Genito-urinary 










Obese I: 30.0-34.9 
Obese II: 35.0-39.9 
Obese III: ≥ 40.0 
FBDR (Florida Birth 
Defects Registry) – 
modified to capture 
maternal pre-
pregnancy weight 
and height in 2014 
Obstructive 
genito-urinary 
defect and renal 
agenesis/hypopla





FBDR, diagnosed within 1st year of 











Sweden Mothers resident in 
Sweden giving birth 
to live infants or 
WHO classification 
based on BMI 
Swedish medical 




759.9 or ICD-10 
Kidney 
agenesis/dysge
 Swedish Medical Birth Registry and 
the Swedish Register of Birth 
Defects both based on data from 
Maternal age, 
parity, smoking in 
20 
 
stillbirth (after 28 
weeks gestation) 
between January 1, 
1995, through 
December 31, 2007 
with Diabetes 
included (1,049,582 
infants, 291 cases 
of kidney 
agenesis/dysgenesis
391 cases of cystic 
kidney) 
including Obesity 
classes I to III 
medical record 
forms completed at 
the maternity 
health care centres 










the neonatal period including 
stillbirths from 28 weeks gestation 
and from the National Patient 
Register which contains 
information on discharge diagnoses 
of all patients admitted to Swedish 
hospitals and was used up to and 
including 2007. Age at diagnosis 
from birth to up to 13 years of age. 
It excluded infants with known 
chromosomal abnormalities 
early pregnancy, 











who gave birth to 
liveborn between 
January 1986 and 
July 2002 at ≥22 
complete weeks of 
gestation at a single 
institution (Hospital 
of the Holy Cross 
and St Paul, 




















or Minor if not 
Renal/Urinary  
. 
Not mentioned, possibly from 



















occurring in <4% 





Sweden Mothers resident in 
Sweden giving birth 
to liveborn 
singleton infants 
from 2001 to 2014 
with diabetes 
included (1,243,957 




based on BMI 
including Obesity 
classes I to III 
Swedish medical 
birth register, based 
on measured 
weight and self-
reported height in 
first trimester at 














Swedish medical birth register 
using standardised prenatal, 
obstetric, and neonatal records, the 
national patient register, cause of 
death register and total population 
register which includes diagnoses 
and dates on visits for hospital 
based inpatient and outpatient 
care, diagnosed by 1 year of age. 
Exclusions: infants with 
chromosomal aberrations, genetic 
syndromes, malformation 
syndromes with known causes, and 
viral infections having a possible 
association with malformations. 
 
Maternal age (13-
24, 25-29, 30-34, 













level (<10, 10-12, 
>12 years), 
maternal country 









with partner, not 
living with 
partner), and sex 
of offspring 
Case--control studies: 
 Obesity CAKUT Control Confounders 
adjusted 





Infants born in the 
five-county 
metropolitan 
Atlanta area during 
1968 –1980, 
excluded if mother 
had diabetes 
Cases = 169 
Controls = 2763 




high BMI = ≥ 25 
low BMI = < 25  
Interviewed by 
telephone in 1982 
and 1983 (pre-
pregnancy weight 



































selected from live 
births 
 to residents of 
metropolitan 






















USA Infants born 
between 1997 and 
2003 in Arkansas, 
California, Iowa, 
Massachusetts, 
New Jersey, New 
York, Texas and 
Atlanta (liveborn or 
liveborn and foetal 
deaths depending 
on state), excluded 
if mother had pre-
pregnancy Diabetes 
 
Cases = 75 
Controls = 868  
 
WHO classification 




interviews within 24 














diagnosed up to 















within 1st year 
of life 
Randomly 
selected at each 
study 
centre by using 






















of whether either 










(after 12 weeks), 
vasoactive 
substance use 
during the first 
trimester, and a 
continuous 
representation of 
the number of 
months that folic 



























A random sample 
of all live born 










1997 and March 
2000. Cases = 87 
Controls = 418 
ascertained by 
four months after 
birth/termination, 
excluding cases 








System of all 
births in 
Western Australia 










between 1997 and 
2010 and included 













based on BMI 
including Obesity 






































Maternal age at 
delivery, smoking, 
education, folic 









Table 2: Summary of quality assessment: green = low risk, yellow = uncertain risk, red = high risk of bias or confounding 
Cohort studies 
 Selection bias Information Bias (Exposure) Information Bias (Outcome) Confounding 
Study Loss to follow up Non-differential 
misclassification of 
exposure 
Recall bias Observer bias Non-differential 
misclassification of 
outcome 





Block          
Blomberg          
García-
Patterson 
         
Persson          
Case-control studies 
Selection Bias Information Bias (Exposure) Information Bias (Outcome) Confounding 
Study Loss to 
follow 
up 
Selection of control Non-differential 
misclassification of 
exposure 
Recall bias Observer bias Non-differential 
misclassification of 
outcome 





Honein           
Oddy           
Slickers           
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Records excluded based on title and 
abstract 
1372 
Full-text articles assessed for eligibility 









Studies included in qualitative synthesis 
8 
Studies included in systematic review 
8 (7 included in meta-analysis) 
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NOTE: Weights are from random effects analysis
.
.






















Urinary system (Obesity Class III)
Renal Agenesis/Hypoplasia
Obstructive Genito-Urinary Defect
Urinary system (Obesity Class II)
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Forest Plot CAKUT and Obesity
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Figure 4: Incidence of CAKUT* in European countries 1980 to 2017 (anomalies included in CAKUT: 
congenital hydronephrosis, posterior urethral valves, prune-belly syndrome, multicystic kidney 
dysplasia and bilateral kidney agenesis) 
 
 
